HomeLonapegsomatropin TcgdLonapegsomatropin Tcgd + Cortisone Acetate

Does Lonapegsomatropin Tcgd Interact with Cortisone Acetate?

Lonapegsomatropin Tcgd and Cortisone Acetate have a moderate drug interaction according to U.S. FDA drug labeling data. SKYTROFA inhibits 11βHSD-1, reducing conversion of cortisone to active cortisol. Patients on glucocorticoid replacement may require increased maintenance or stress doses. The mechanism involves inhibition of microsomal enzyme 11β-hydroxysteroid dehydrogenase type 1 (11βhsd-1). Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Lonapegsomatropin Tcgd Class
Recombinant Human Growth Hormone
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Lonapegsomatropin Tcgd and Cortisone Acetate occurs because inhibition of microsomal enzyme 11β-hydroxysteroid dehydrogenase type 1 (11βhsd-1). Clinically, this means skytrofa inhibits 11βhsd-1, reducing conversion of cortisone to active cortisol. patients on glucocorticoid replacement may require increased maintenance or stress doses. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Lonapegsomatropin Tcgd and your doctor is considering prescribing Cortisone Acetate (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Lonapegsomatropin Tcgd(Skytrofa)+💊 Cortisone Acetate

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Recombinant Human Growth Hormone
Drug B class
Source
NLP:lonapegsomatropin-tcgd

What this means in plain English

SKYTROFA inhibits 11βHSD-1, reducing conversion of cortisone to active cortisol. Patients on glucocorticoid replacement may require increased maintenance or stress doses.

About Lonapegsomatropin Tcgd and Cortisone Acetate

Lonapegsomatropin Tcgd is a Recombinant Human Growth Hormone. Lonapegsomatropin Tcgd is also sold under the brand name Skytrofa. Lonapegsomatropin Tcgd is given by injection under the skin.

What the FDA label says

"Inhibition of microsomal enzyme 11β-hydroxysteroid dehydrogenase type 1 (11βHSD-1)"

📖 Source: NLP:lonapegsomatropin-tcgd

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Lonapegsomatropin Tcgd and Cortisone Acetate against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.